Showing results for Pierce Logan, MA
-
![]()
On the Increase in Use of GLP-1s
GLP-1 agonists, which include Ozempic, Mounjaro, and Wegovy, are already FDA-approved for type-2 diabetes, weight loss, and heart disease. Research shows a 40-fold increase in ...
Author
Pierce Logan, MA
Pierce is a graduate assistant at the IU Center for Bioethics with an MA in philosophy.
The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.